Provided is a pharmaceutical composition suitable for lymphogenous drug administration in which an anticancer drug is administered into a lymph node. The pharmaceutical composition which is for cancer therapy or prophylactic therapy and which is administered into a lymph node, contains, as an active ingredient, at least one anticancer drug selected from antimetabolites and plant alkaloid-based anticancer drugs.